Search results for CD79b antibody

APC Anti-CD79b antibody [SP240], Abcam, AB306479

This conjugated primary antibody is "made to order" and it is released using a quantitative quality control method that ensures binding affinity and labelling efficiency of the conjugate. Via leveraging the power of the Lightning-Link ® conjugation technology , Abcam will deliver highly consistent recombinant conjugates in <2 weeks, giving you access to an ever growing portfolio of antibody-label combinations. For suitable applications and species reactivity, please refer to the unconjugated version of this clone. How are conjugated primary antibodies validated? This conjugated primary antibody is released using a quantitative quality control method that evaluates binding affinity post-conjugation and efficiency of antibody labeling. For suitable applications and species reactivity, please refer to the unconjugated version of this clone. Patented technology Our RabMAb ® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb ® patents . What are the advantages of a recombinant monoclonal antibody? This product is a recombinant monoclonal antibody, which offers several advantages including: - High batch-to-batch consistency and reproducibility - Improved sensitivity and specificity - Long-term security of supply - Animal-free batch production For more information, read more on recombinant antibodies .

Anti-CD79β/CD79B Antibody (R3K34), AntibodySystem, RHE26301

CD79b antibody [HM79-11] (PE), Genetex, GTX75400

CD79b antibody [AT105-1] (PE), Genetex, GTX75967

CD79b antibody [AT107-2] (FITC), Genetex, GTX75969

CD79b antibody (CB3-1) [FITC], Covalab, Ref 00114810

CD79b antibody (CB3-1) [PE], Covalab, Ref 00114811

CD79b antibody (CB3-1) [APC], Covalab, Ref 00114809

PE Anti-CD79b antibody [AT105-1], Abcam, AB33295

PE Anti-CD79b antibody [CB3-1], Abcam, AB269288